CME/CE Podcast - Integrating TROP2-Directed ADCs into TNBC Treatment Plans: Novel Aspects of Efficacy and Safety Profiles
About this episode
This CME/CE-certified podcast provides an update on TROP2-directed ADCs in treating metastatic triple-negative breast cancer.
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/the-evolving-role-of-antibody-drug-conjugates-in-metastatic-triple-negative-breast-cancer-10800 Summary This CME/CE-certified podcast will provide multidisciplinary clinicians with an evidence-based update on the evolving role of TROP2-directed antibody-drug conjugates (ADCs) in the frontline treatment of metastatic triple-negativ...
More episodes of The NACE Clinical Highlights Show
Explore listener stats, chart rankings, contacts and more on the The NACE Clinical Highlights Show podcast page.